BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11594576)

  • 1. Treatment of cutaneous T cell lymphoma stage II with interferon-alpha-2a and extracorporeal photochemotherapy: a prospective controlled trial.
    Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
    Ann N Y Acad Sci; 2001 Sep; 941():210-3. PubMed ID: 11594576
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
    Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
    J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma.
    Zachariae H; Thestrup-Pedersen K
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):206S-208S. PubMed ID: 2258637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients with cutaneous T cell lymphoma after treatment with extracorporeal photochemotherapy: a retrospective single-center analysis.
    Wollina U; Liebold K; Kaatz M; Looks A; Stuhlert A; Lange D
    Ann N Y Acad Sci; 2001 Sep; 941():217-9. PubMed ID: 11594578
    [No Abstract]   [Full Text] [Related]  

  • 5. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
    Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
    J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
    Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
    Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial regrowth of scalp hair in a patient treated with extracorporeal photochemotherapy and interferon alpha 2a.
    Wollina U
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):261-2. PubMed ID: 9883441
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
    Stadler R; Otte HG
    Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
    Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
    Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
    Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic treatment for cutaneous lymphomas.
    Mielke V; Staib G; Sterry W
    Recent Results Cancer Res; 1995; 139():403-8. PubMed ID: 7597307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma.
    Fimiani M; Rubegni P; De Aloe G; Andreassi L
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):502-3. PubMed ID: 10459134
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
    Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ
    Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal photochemotherapy in long-term treatment of early stage cutaneous T-cell lymphoma.
    Rubegni P; De Aloe G; Fimiani M
    Br J Dermatol; 2000 Oct; 143(4):894-6. PubMed ID: 11069483
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma.
    Zackheim HS
    J Am Acad Dermatol; 2000 Jun; 42(6):1087-8. PubMed ID: 10827420
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternating recombinant and natural alpha-interferon helps to prevent clinical resistance to interferon in cutaneous T-cell lymphoma treatment.
    Altomare G; Capella GL; Frigerio E
    Acta Derm Venereol; 1998 Mar; 78(2):159. PubMed ID: 9534907
    [No Abstract]   [Full Text] [Related]  

  • 17. U.K. national audit of extracorporeal photopheresis in cutaneous T-cell lymphoma.
    Sanyal S; Child F; Alfred A; Callaghan T; Alband N; Whittaker S; Cowan R; Parry E; Robinson S; Dunnill MGS; Wain M; Morris S; Malladi R; Tahir S; Howles A; Arumainathan A; Azurdia R; Grant-Casey J; Matin RN; Gilson D; Howell C; El-Gheriani K; Taylor P; Scarisbrick J
    Br J Dermatol; 2018 Feb; 178(2):569-570. PubMed ID: 28782100
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma.
    Dippel E; Schrag H; Goerdt S; Orfanos CE
    Lancet; 1997 Jul; 350(9070):32-3. PubMed ID: 9217723
    [No Abstract]   [Full Text] [Related]  

  • 19. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
    Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of non-AIDS Kaposi sarcoma during therapy with interferon alfa-2a in an 82-year-old man with concomitant cutaneous T-cell lymphoma.
    Giuliani M; Mastroianni A; Di Carlo A; Donati P; Miceli M; Monini P; Rezza G
    Arch Dermatol; 2002 Apr; 138(4):535-7. PubMed ID: 11939825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.